![]() Chrysalis BioTherapeutics ChrysalisBioTherapeutics is a biopharmaceutical company developing regenerative drugs. | Atea Pharmaceuticals Atea Pharmaceuticals is a biopharmaceutical company specializing in oral direct-acting antiviral therapies. | ![]() Selva Therapeutics Selva Therapeutics is a biotechnology company dedicated to the development of therapeutics for infectious diseases. | Centivax Centivax is a vaccine platform biotechnology company aiming to treat and eradicate rapidly mutating pathogens. | ![]() ExeVir Bio ExeVir Bio is a company that harnesses a llama-derived antibody technology platform to generate antiviral therapies providing broad protection against coronaviruses. | |
Founding Date | Founding Date 2012 | Founding Date 2014 | Founding Date N/A | Founding Date 2019 | Founding Date 2020 |
Type | Type Private | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Galveston, US HQ | Locations Boston, US HQ Boston, US | Locations San Diego, US HQ | Locations South San Francisco, US HQ | Locations Gent, BE HQ |
Employees | Employees 6 | Employees 552% decrease | Employees 4 | Employees 274% increase | Employees 1611% decrease |
Funding | |||||
Latest funding round | Latest funding round $ 10.4m (over 5 years ago) | Latest funding round N/A | Latest funding round $ 3m (almost 6 years ago) | Latest funding round N/A | Latest funding round $ 23m (almost 5 years ago) |
Total funding raised | Total funding raised $ 11m | Total funding raised N/A | Total funding raised $ 3m | Total funding raised N/A | Total funding raised $ 50m |
Atea Pharmaceuticals is a biopharmaceutical company specializing in oral direct-acting antiviral therapies.
View company
Selva Therapeutics is a biotechnology company dedicated to the development of therapeutics for infectious diseases.
View companyCentivax is a vaccine platform biotechnology company aiming to treat and eradicate rapidly mutating pathogens.
View company
ExeVir Bio is a company that harnesses a llama-derived antibody technology platform to generate antiviral therapies providing broad protection against coronaviruses.
View company